Postprocedural disorders of nervous system

G6_POSTOPNEURO

nervous system disease: A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G97 Hospital discharge: ICD-9 — 3490\|9970 Cause of death: ICD-10 — G97 Cause of death: ICD-9 — 3490\|9970 2 out of 7 registries used, show all original rules.	3189
4. Check minimum number of events None	3189
5. Include endpoints None	3189
6. Filter based on genotype QC (FinnGen only)	3088

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G90-G99
Name in latin: Morbositates systematis nervosi post interventiones non alibi classificatae

NAME	G6_POSTOPNEURO
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G97
HD_ICD_9	3490\|9970
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G97
COD_ICD_9	3490\|9970
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Postprocedural disorders of nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17984	12561	5331
Only index persons	17409	12324	5085
Unadjusted period prevalence (%)
Whole population	0.30	0.36	0.15
Only index persons	0.38	0.45	0.19
Median age at first event (years)
Whole population	34.51	34.74	33.96
Only index persons	34.38	34.68	33.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3088	2396	692
Unadjusted period prevalence (%)	0.73	0.85	0.32
Median age at first event (years)	37.04	36.15	40.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3189: Matched controls
31890

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

+∞

307.7

356

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

178.3

307.7

1189

106

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.6

307.7

663

1224

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4503599627370496.0

307.7

2485

R51.80

ICD-10 Finland

Headache

5.3

307.7

1281

3601

TAB00

NOMESCO Finland

Lumbar puncture

18.4

307.7

847

616

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.2

246.4

578

1299

3490A

ICD-9 Finland

Other and unspecified disorders of the nervous system, Reaction to spinal or lumbar puncture

+∞

237.5

225

R20.2

ICD-10 Finland

Paraesthesia of skin

5.1

230.6

547

1238

AA1AD

NOMESCO Finland

CT of head and brain

3.5

203.5

908

3242

G35

ICD-10 Finland

Multiple sclerosis

9.5

189.1

231

260

N03AX12

ATC

[U] gabapentin; oral

3.4

175.1

769

2692

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

19.1

160.8

127

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.1

160.7

498

1372

109

Kela drug reimbursment

Multiple sclerosis

9.9

156.9

185

198

G44.2

ICD-10 Finland

Tension-type headache

3.1

145.2

786

3082

N03AX16

ATC

[U] pregabalin

2.8

139.6

929

4065

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

9.9

137.8

161

170

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

9.5

131.3

159

176

N02AX02

ATC

tramadol; systemic, rectal

2.5

130.8

1478

8295

R42

ICD-10 Finland

Dizziness and giddiness

2.8

129.2

834

3574

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.5

118.0

310

748

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

116.1

1550

9217

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.3

114.5

315

787

ZXD05

NOMESCO Finland

Urgent procedure

2.4

113.0

1260

6918

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

11.3

109.7

116

106

N06AX21

ATC

duloxetine; oral

2.9

109.6

599

2329

H46

ICD-10 Finland

Optic neuritis

9.7

109.2

129

138

G43.9

ICD-10 Finland

Migraine, unspecified

3.3

108.6

456

1521

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

102.6

669

2846

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.1

95.3

442

1559

G97.8

ICD-10 Finland

Other postprocedural disorders of nervous system

481.9

94.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.2

92.9

114

128

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.0

90.2

458

1698

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

88.5

385

1305

XA800

NOMESCO Finland

Neuropsychological investigation

4.5

88.2

224

524

L03AX13

ATC

glatiramer acetate; parenteral

12.2

86.8

N06AA09

ATC

amitriptyline; systemic

3.2

86.2

369

1238

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.3

83.2

794

3989

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

78.9

1112

6501

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.9

78.0

178

381

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.8

77.6

146

263

R51

ICD-10 Finland

Headache

3.1

74.6

335

1153

M03BX01

ATC

baclofen; systemic

6.2

73.8

128

213

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.4

73.8

280

869

M79.6

ICD-10 Finland

Pain in limb

2.0

73.5

1473

9695

N03AX11

ATC

topiramate; oral

4.4

73.4

189

446

A02BC05

ATC

esomeprazole; systemic

2.0

71.0

1344

8647

N06AX16

ATC

venlafaxine; oral

2.3

70.2

662

3282

H02AB06

ATC

prednisolone; systemic

1.9

69.8

1534

10357

M25.5

ICD-10 Finland

Pain in joint

2.0

69.6

1230

7716

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

69.2

412

1651

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

68.7

803

4337

A02BC02

ATC

pantoprazole; systemic

2.0

67.8

2121

16027

N86

ICPC

Multiple sclerosis

10.5

67.8

M03BX02

ATC

tizanidine; oral

2.0

67.3

2206

16915

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.5

66.4

130

243

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.4

66.3

548

2562

H53.1

ICD-10 Finland

Subjective visual disturbances

3.1

65.4

291

994

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

65.1

703

3672

H53.2

ICD-10 Finland

Diplopia

4.9

64.5

147

314

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

64.5

1133

7053

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

64.5

345

1306

L03AB07

ATC

interferon beta-1a; parenteral

8.7

63.7

N02BE01

ATC

paracetamol; systemic, rectal

2.7

63.5

2869

24542

164

Kela drug reimbursment

Fingolimod

11.9

62.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

62.6

492

2245

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

62.0

1489

10217

G93.2

ICD-10 Finland

Benign intracranial hypertension

+∞

61.7

M54.5

ICD-10 Finland

Low back pain

1.9

59.9

1318

8772

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

59.8

844

4851

N02BF01

ATC

gabapentin; oral

2.8

59.5

328

1259

UKC02

NOMESCO Finland

Cystoscopy

2.6

59.4

371

1518

N06AX11

ATC

mirtazapine; oral

1.9

58.8

1161

7456

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

57.6

1176

7621

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.7

56.3

106

191

XCK00

NOMESCO Finland

Perimetry

3.6

55.8

195

572

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

55.1

671

3643

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.1

55.1

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

54.6

785

4520

G97.9

ICD-10 Finland

Postprocedural disorder of nervous system, unspecified

+∞

54.3

R52.2

ICD-10 Finland

Other chronic pain

3.7

54.1

177

497

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

53.9

668

3647

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.3

53.3

109

212

A02BC03

ATC

lansoprazole; oral

1.9

53.0

848

5055

N03AE01

ATC

clonazepam; systemic

3.1

52.8

229

768

L04AA27

ATC

[U] fingolimod

13.4

52.0

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

51.7

350

1485

R53

ICD-10 Finland

Malaise and fatigue

1.9

51.3

854

5150

G43.3

ICD-10 Finland

Complicated migraine

4.3

51.3

136

328

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

51.2

737

4234

R03AC02

ATC

salbutamol; inhalant

1.8

51.1

1908

14595

S01EC01

ATC

acetazolamide; systemic

6.2

50.9

146

XKD00

NOMESCO Finland

Uroflowmetry

2.8

50.6

278

1063

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

50.5

879

5372

353

Kela drug reimbursment

Cladribine and fingolimod

11.0

50.4

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

9.5

49.9

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.3

49.2

R50.9

ICD-10 Finland

Fever, unspecified

2.1

49.1

520

2668

G97.2

ICD-10 Finland

Intracranial hypotension following ventricular shunting

+∞

49.1

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.7

48.1

156

435

N06BA07

ATC

modafinil; oral

10.8

48.0

R1250

NOMESCO Finland

Evaluation of functional capability

4.8

47.5

108

230

M01AE02

ATC

naproxen; oral, rectal

1.7

47.5

1960

15273

J01AA02

ATC

doxycycline; systemic

1.9

47.4

2413

19974

R11

ICD-10 Finland

Nausea and vomiting

2.5

46.7

332

1439

N05BA04

ATC

oxazepam; oral

1.8

46.4

873

5444

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.5

46.3

L04AX07

ATC

dimethyl fumarate; oral

8.5

46.3

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

46.3

571

3096

N03AX09

ATC

lamotrigine; oral

2.7

46.1

262

1018

M79.7

ICD-10 Finland

Fibromyalgia

3.2

45.7

191

626

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.5

45.3

160

472

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

45.3

743

4432

M01AH05

ATC

etoricoxib; oral

1.7

45.2

2021

15994

R06.0

ICD-10 Finland

Dyspnoea

1.9

45.2

738

4397

H47.1

ICD-10 Finland

Papilloedema, unspecified

11.1

45.1

G44.8

ICD-10 Finland

Other specified headache syndromes

4.6

44.7

107

238

SPAT1301

SPAT

No procedures

1.8

44.5

926

5938

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.8

44.2

100

212

A02BC01

ATC

omeprazole; systemic

1.8

44.2

804

4951

SPAT1263

SPAT

Sampling

1.7

44.1

1367

9789

J01FA10

ATC

azithromycin; systemic

1.7

43.9

2071

16561

P01AB01

ATC

metronidazole; oral, rectal

1.7

43.9

1379

9906

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

155.5

43.9

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

6.4

43.2

115

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

223.0

43.0

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

42.8

1375

9915

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

42.6

628

3611

C07AA05

ATC

propranolol; systemic

1.8

42.4

785

4849

J01MA02

ATC

ciprofloxacin; systemic

1.7

42.1

1063

7180

M79.1

ICD-10 Finland

Myalgia

1.9

41.2

574

3235

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

41.1

1013

6788

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

9.9

41.0

N05AH04

ATC

quetiapine; oral

1.9

41.0

678

4041

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

40.9

698

4200

N01

ICPC

Headache

2.0

40.5

513

2796

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

40.4

415

2094

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

40.1

248

1004

R55

ICD-10 Finland

Syncope and collapse

2.4

40.0

283

1221

K30

ICD-10 Finland

Functional dyspepsia

2.1

39.9

419

2132

M01AB05

ATC

diclofenac; systemic, rectal

1.7

39.8

2102

17084

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

6.4

39.8

105

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

39.5

232

916

J01DB01

ATC

cefalexin; oral

1.9

39.2

2686

23438

SPAT1153

SPAT

Removal of sutures

1.8

38.8

823

5272

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

7.9

38.7

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.2

38.6

156

501

UJF32

NOMESCO Finland

Coloscopy

1.8

38.5

655

3928

A02BA02

ATC

ranitidine; systemic

2.0

38.4

495

2711

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.5

38.4

138

412

R51.81

ICD-10 Finland

Facial pain NOS

3.8

38.4

121

331

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.8

38.3

199

737

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

38.2

784

4972

M54.2

ICD-10 Finland

Cervicalgia

2.3

37.9

311

1431

G50.1

ICD-10 Finland

Atypical facial pain

4.4

37.7

220

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

37.6

391

1980

C07AB07

ATC

bisoprolol; oral

1.7

37.4

1046

7210

N06AA10

ATC

nortriptyline; systemic

3.9

37.3

110

287

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.3

37.1

227

R01AD09

ATC

mometasone; nasal

1.6

37.1

1631

12569

XKC03

NOMESCO Finland

Water cystometry

4.1

37.0

102

253

H02AB04

ATC

methylprednisolone; systemic

2.0

36.9

445

2378

A01

ICPC

Pain general/multiple sites

2.3

36.6

296

1354

L04AA31

ATC

[U] teriflunomide

9.3

36.6

2309

FHL

Other measure in this category

44.6

36.0

R52.9

ICD-10 Finland

Pain, unspecified

2.2

35.5

334

1625

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

35.5

782

5045

N06AB04

ATC

citalopram; systemic

1.8

35.2

676

4192

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

35.1

591

3524

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

351.1

35.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

35.0

440

2384

N02AA05

ATC

oxycodone; systemic

2.1

34.7

362

1832

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

34.4

M01AC06

ATC

meloxicam; systemic, rectal

1.6

34.3

1029

7186

M01AH01

ATC

celecoxib; oral

1.9

34.0

478

2688

N04BB01

ATC

amantadine; oral

5.0

34.0

152

S06.0

ICD-10 Finland

Concussion

2.1

34.0

361

1840

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

33.9

429

2328

N29

ICPC

Neurological sympt/complt other

4.6

33.9

176

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

33.8

381

1985

N03AF01

ATC

carbamazepine; oral, rectal

2.9

33.8

159

558

N06AB10

ATC

escitalopram; oral

1.7

33.5

822

5445

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

33.5

320

1565

J01FA06

ATC

roxithromycin; oral

1.6

33.4

1231

9023

Z00.0

ICD-10 Finland

General medical examination

1.8

33.4

590

3565

G50.0

ICD-10 Finland

Trigeminal neuralgia

4.4

33.3

199

J01EA01

ATC

trimethoprim; systemic

1.7

33.1

826

5495

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

33.1

493

2824

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.9

33.1

160

570

J02AC01

ATC

fluconazole; systemic

1.6

32.9

1468

11236

L03AB08

ATC

interferon beta-1b; parenteral

9.4

32.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

32.5

209

861

R20.0

ICD-10 Finland

Anaesthesia of skin

6.6

32.4

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

32.1

412

2244

G45.3

ICD-10 Finland

Amaurosis fugax

62.4

32.1

N07XX09

ATC

[U] dimethyl fumarate

10.1

31.8

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.7

31.7

174

663

N05CF01

ATC

zopiclone; oral

1.7

31.7

850

5751

A87.9

ICD-10 Finland

Viral meningitis, unspecified

6.3

31.3

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

31.0

899

6195

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

30.9

448

2540

X58

ICD-10 Finland

Exposure to other specified factors

1.8

30.8

487

2838

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

30.4

1611

12724

SPAT1260

SPAT

Consultation of another employee

1.8

30.0

517

3091

K07.60

ICD-10 Finland

Snapping jaw

2.3

29.9

252

1170

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

29.9

146

523

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

29.8

371

1997

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

29.8

1930

15895

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.2

29.7

191

G54.0

ICD-10 Finland

Brachial plexus disorders

3.0

29.7

138

481

G04BD12

ATC

mirabegron; oral

2.2

29.4

248

1153

N02CC04

ATC

rizatriptan; oral

2.1

29.3

280

1367

R13

ICD-10 Finland

Dysphagia

2.5

29.3

195

816

G44.0

ICD-10 Finland

Cluster headache syndrome

4.5

29.2

164

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

29.1

219

969

R52.1

ICD-10 Finland

Chronic intractable pain

5.8

29.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

28.9

232

1056

SPAT1310

SPAT

Counselling related to known health issue

1.6

28.7

950

6736

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.8

28.6

237

R03DC03

ATC

montelukast; oral

1.7

28.5

586

3683

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

28.3

264

1277

N05CF02

ATC

zolpidem; oral

1.7

28.2

567

3539

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

28.1

285

1424

M01AH02

ATC

rofecoxib; oral

2.1

28.1

292

1473

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.6

28.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

27.9

258

1243

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

27.9

435

2518

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.7

27.9

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

27.8

927

6572

PA7BD

NOMESCO Finland

CT angiography of neck and brain

6.5

27.7

Z2445

NOMESCO Finland

Psychologist

2.6

27.7

171

691

R01AD58

ATC

fluticasone, combinations; nasal

1.6

27.6

963

6897

N02CC03

ATC

zolmitriptan; nasal, oral

2.1

27.6

263

1283

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

27.5

285

1435

N05BA01

ATC

diazepam; systemic, rectal

1.9

27.5

375

2080

G43.8

ICD-10 Finland

Other migraine

3.4

27.5

101

306

R07.3

ICD-10 Finland

Other chest pain

2.0

27.4

300

1541

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

27.3

220

1002

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.5

27.3

278

J05AB01

ATC

aciclovir; systemic

1.6

27.2

704

4695

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

27.1

186

790

AA1AA

NOMESCO Finland

Head X-ray examination

9.0

26.8

TAB20

NOMESCO Finland

Epidural puncture

6.1

26.7

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

26.6

297

1537

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

26.5

1707

13884

H57.1

ICD-10 Finland

Ocular pain

2.6

26.3

160

642

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.5

26.3

175

733

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

26.0

272

1375

TKC22

NOMESCO Finland

Catheterisation instruction

5.1

25.9

107

L28

ICPC

Limited function/disability (L)

1.9

25.8

363

2031

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

25.8

188

820

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.5

25.8

264

J01DA01

ATC

[U] cefalexin

1.5

25.8

1908

15921

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

25.7

131

480

D01

ICPC

Abdominal pain/cramps general

1.8

25.7

417

2442

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

25.6

679

4546

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

25.5

359

2009

M01AX17

ATC

nimesulide; oral

1.7

25.5

550

3492

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

7.6

25.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

25.4

525

3294

A06AD11

ATC

lactulose; oral

2.0

25.4

291

1520

N03AG01

ATC

valproic acid; systemic, rectal

2.3

25.4

207

948

Z3231

NOMESCO Finland

Registered nurse

1.6

25.3

738

5054

N02CC07

ATC

frovatriptan; oral

2.2

25.3

222

1048

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

25.0

302

1607

N06AB06

ATC

sertraline; oral

1.8

24.9

427

2539

R06AE07

ATC

cetirizine; oral

1.5

24.9

1482

11807

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.5

24.9

154

623

C09CA06

ATC

candesartan; oral

1.6

24.8

638

4235

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

24.8

321

1748

N03AF02

ATC

oxcarbazepine; oral

2.9

24.7

119

423

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.9

24.6

112

J01FF01

ATC

clindamycin; systemic

1.6

24.6

770

5358

R20.1

ICD-10 Finland

Hypoaesthesia of skin

6.2

24.5

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.9

24.5

119

425

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

24.5

288

1517

N02CC06

ATC

eletriptan; oral

2.3

24.5

186

826

J01CA04

ATC

amoxicillin; systemic

1.7

24.4

2680

24201

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

24.2

2418

21317

G04CA02

ATC

tamsulosin; oral

2.0

24.2

283

1488

N04BC05

ATC

pramipexole; oral

2.3

24.0

198

910

N89

ICPC

Migraine

2.3

24.0

195

891

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

24.0

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

24.0

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

23.9

428

2577

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

23.8

311

1697

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

23.8

2322

20316

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

23.8

323

1785

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

23.8

1223

9439

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

23.7

1087

8201

N02CC05

ATC

almotriptan; oral

2.2

23.7

196

903

M89.0

ICD-10 Finland

Algoneurodystrophy

4.8

23.6

112

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

23.6

193

885

R03BA08

ATC

ciclesonide; inhalant

2.0

23.6

292

1566

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

23.5

257

1318

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

23.5

551

3569

SPAT1254

SPAT

Administration of medicine

1.8

23.4

373

2168

J45

ICD-10 Finland

Asthma

1.9

23.4

348

1980

SPAT1240

SPAT

Therapeutic discussion

1.7

23.4

439

2677

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

23.3

736

5123

J05AB11

ATC

valaciclovir; oral

1.7

23.2

451

2777

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

23.1

221

1078

R03BA05

ATC

fluticasone; inhalant

1.6

23.1

587

3878

R33

ICD-10 Finland

Retention of urine

2.6

23.0

133

520

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

23.0

339

1924

G62.8

ICD-10 Finland

Other specified polyneuropathies

6.7

22.9

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

22.9

1789

14918

J01FA09

ATC

clarithromycin; systemic

1.5

22.9

995

7410

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

22.8

298

1626

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

22.7

221

1085

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

22.7

119

443

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.7

22.7

203

W19

ICD-10 Finland

Unspecified fall

2.0

22.6

261

1366

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.9

22.6

286

1545

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

22.5

380

2246

N02BF02

ATC

pregabalin; oral

2.2

22.5

192

895

R03BA01

ATC

beclometasone; inhalant

1.7

22.2

408

2472

R00.2

ICD-10 Finland

Palpitations

1.9

22.1

283

1534

N07CA01

ATC

betahistine; oral

2.3

22.0

172

774

R01AD12

ATC

fluticasone furoate; nasal

1.5

21.9

1160

8965

M54.3

ICD-10 Finland

Sciatica

2.2

21.9

192

905

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

21.9

SPAT1229

SPAT

Assessment of need for aid

2.4

21.9

153

655

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.0

21.8

266

1419

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

6.5

21.7

L03

ICPC

Low back symptom/complaint

1.5

21.7

867

6335

G72.9

ICD-10 Finland

Myopathy, unspecified

6.7

21.7

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

21.7

157

683

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

21.5

544

3583

S18

ICPC

Laceration/cut

1.5

21.4

1138

8791

N99

ICPC

Neurological disease other

5.1

21.4

C10AC01

ATC

colestyramine; oral

3.0

21.4

334

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

21.3

212

1051

G43

ICD-10 Finland

Migraine

1.9

21.2

272

1475

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

21.2

133

542

C08DA01

ATC

verapamil; systemic

2.8

21.1

108

397

C01CA24

ATC

epinephrine; parenteral

2.0

21.0

257

1371

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

21.0

160

712

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

3.0

20.9

306

N30.0

ICD-10 Finland

Acute cystitis

1.6

20.9

506

3297

R06AX27

ATC

desloratadine; oral

1.5

20.9

1048

8002

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

20.8

877

6466

J01DA09

ATC

[U] cefadroxil

1.5

20.7

823

5995

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

20.7

2941

27496

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

20.7

495

3214

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

20.6

542

3601

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

20.6

432

2710

R01AD08

ATC

fluticasone; nasal

1.5

20.6

951

7138

B01AB05

ATC

enoxaparin; parenteral

1.5

20.6

751

5375

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

20.5

144

618

R39.1

ICD-10 Finland

Other difficulties with micturition

3.3

20.5

232

SPAT1050

SPAT

Extensive neurological examination

3.5

20.3

199

XA402

NOMESCO Finland

ENMG

3.1

20.3

290

J01CA08

ATC

pivmecillinam; oral

1.4

20.2

1392

11243

K08.80

ICD-10 Finland

Toothache NOS

1.8

20.2

337

1982

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

20.2

606

4153

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

20.1

144

623

SPAT1216

SPAT

Assessment of functional ability

1.8

20.1

295

1669

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

20.1

220

G93.3

ICD-10 Finland

Postviral fatigue syndrome

6.8

20.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

19.9

187

906

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

19.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

19.8

1047

8056

N06AX26

ATC

vortioxetine; oral

1.9

19.7

285

1605

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

19.7

209

1060

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

19.7

344

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

19.7

869

6455

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

19.7

995

7588

A03FA02

ATC

cisapride; oral, rectal

2.2

19.6

171

804

M54.1

ICD-10 Finland

Radiculopathy

2.4

19.6

133

562

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

19.6

244

1310

L08

ICPC

Shoulder symptom/complaint

1.6

19.4

573

3906

R35

ICD-10 Finland

Polyuria

2.3

19.4

152

684

XF404

NOMESCO Finland

Ambulatory ECG

2.1

19.4

191

942

SFA10

NOMESCO Finland

One-surface restoration

1.4

19.3

1784

15123

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.1

19.3

178

857

N06AX12

ATC

bupropion; oral

1.8

19.2

307

1784

R21

ICPC

Throat symptom/complaint

1.5

19.2

833

6164

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.9

19.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

19.2

279

1575

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

19.1

1068

8287

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.7

19.1

101

378

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

19.1

398

2492

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

19.0

307

1789

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

55.4

18.9

M22.4

ICD-10 Finland

Chondromalacia patellae

2.4

18.9

136

590

A04AA01

ATC

ondansetron; systemic, rectal

2.0

18.9

215

1118

R4120

NOMESCO Finland

Occupational therapy

2.1

18.9

189

938

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

4.0

18.9

134

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

18.8

381

2366

R02

ICPC

Shortness of breath/dyspnoea

1.8

18.8

322

1909

H81.3

ICD-10 Finland

Other peripheral vertigo

3.1

18.7

261

N06AX03

ATC

mianserin; oral

2.4

18.7

132

568

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.8

18.7

G47.3

ICD-10 Finland

Sleep apnoea

1.6

18.7

560

3830

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

18.6

678

4838

M01AC01

ATC

piroxicam; systemic, rectal

1.8

18.6

295

1710

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

18.6

147

665

R03BA02

ATC

budesonide; inhalant

1.6

18.5

545

3713

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

18.3

917

6959

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.3

18.3

203

G04BD08

ATC

solifenacin; oral

2.3

18.3

134

586

ZXA05

NOMESCO Finland

Left side

1.6

18.3

534

3628

G51.0

ICD-10 Finland

Bell palsy

2.9

18.3

297

A01AB04

ATC

amphotericin B; local oral

2.6

18.3

106

416

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

18.3

122

512

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

18.3

218

1153

M02AA07

ATC

piroxicam; topical

1.5

18.2

842

6293

Z71.8

ICD-10 Finland

Other specified counselling

1.4

18.2

988

7609

A03

ICPC

Fever

1.5

18.1

616

4327

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.2

18.1

235

R96

ICPC

Asthma

1.8

18.1

267

1514

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

18.0

298

1747

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

18.0

138

616

S83.2

ICD-10 Finland

Tear of meniscus, current

2.0

17.8

209

1098

H02AB09

ATC

hydrocortisone; systemic

2.9

17.8

296

CS494

NOMESCO Finland

Other visual field testing

3.3

17.8

212

Z3226

NOMESCO Finland

Physiotherapist

1.6

17.8

466

3087

L01

ICPC

Neck symptom/complaint

1.6

17.7

500

3371

C07AB02

ATC

metoprolol; systemic

1.7

17.7

354

2191

C08CA05

ATC

nifedipine; systemic

2.3

17.6

135

602

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

17.6

1250

10075

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

17.6

447

2937

ZXA10

NOMESCO Finland

Bilateral

1.6

17.6

425

2760

N05BA12

ATC

alprazolam; oral

1.8

17.6

287

1677

N18

ICPC

Paralysis/weakness

4.6

17.5

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

17.5

446

2934

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.7

17.4

367

R03AC03

ATC

terbutaline; inhalant

1.6

17.4

430

2808

A02BC04

ATC

rabeprazole; oral

1.8

17.3

270

1557

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.2

17.2

152

719

J46

ICD-10 Finland

Status asthmaticus

2.7

17.1

331

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

17.1

433

2844

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

17.1

140

643

ZXA00

NOMESCO Finland

Right side

1.5

17.0

566

3955

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

16.9

239

1335

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

16.9

103

414

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

16.9

423

2768

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.0

16.9

261

R12

ICD-10 Finland

Heartburn

1.8

16.9

245

1381

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.5

16.8

102

409

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.0

16.8

190

986

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

16.7

220

M23.8

ICD-10 Finland

Other internal derangements of knee

2.2

16.7

138

636

XQ800

NOMESCO Finland

Prick test

1.8

16.7

284

1679

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

+∞

16.7

SPAT1097

SPAT

Recording of ECG

1.7

16.7

296

1771

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.2

16.6

206

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

170.9

16.5

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

16.4

122

537

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.6

16.4

379

N06AX22

ATC

agomelatine; oral

2.5

16.4

103

421

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

16.3

208

1124

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.7

16.3

316

R06.4

ICD-10 Finland

Hyperventilation

3.1

16.3

213

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.9

16.2

256

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

16.2

209

1134

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.3

16.1

184

A06AC51

ATC

ispaghula, combinations; oral

2.2

16.1

134

619

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.2

16.0

134

620

H93.1

ICD-10 Finland

Tinnitus

2.0

16.0

186

974

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

16.0

596

4255

J01MA14

ATC

moxifloxacin; systemic

1.8

16.0

226

1263

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.1

15.9

150

728

G04CA01

ATC

alfuzosin; oral

2.1

15.9

158

783

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

15.8

1076

8570

R05

ICD-10 Finland

Cough

1.5

15.8

592

4230

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

15.8

300

1827

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

15.7

355

2264

SPAT1312

SPAT

General health counselling

1.4

15.7

936

7292

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

4.9

15.7

A04

ICPC

Weakness/tiredness general

1.6

15.7

422

2808

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.1

15.7

208

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

15.6

251

1459

R09

ICPC

Sinus symptom/complaint

1.7

15.6

319

1983

DFF00

NOMESCO Finland

Pure tone audiometry

1.9

15.6

217

1207

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

15.6

141

674

J01FA15

ATC

telithromycin; oral

1.7

15.6

301

1843

G93.0

ICD-10 Finland

Cerebral cysts

85.5

15.6

L12

ICPC

Hand/finger symptom/complaint

1.5

15.5

472

3227

M35.7

ICD-10 Finland

Hypermobility syndrome

2.8

15.5

285

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

160.8

15.5

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

15.5

182

958

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

15.4

334

2107

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

15.4

191

1023

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

15.4

669

4921

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

15.4

117

521

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

15.3

394

2592

SPAT1255

SPAT

Intravenous administration of medicine

2.0

15.3

160

807

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.4

15.3

160

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.0

15.3

175

912

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

15.3

184

976

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

15.2

689

5104

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

5.5

15.2

H03AA01

ATC

levothyroxine sodium; systemic

1.5

15.2

657

4826

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

15.2

189

1014

M01AB55

ATC

diclofenac, combinations; oral

2.1

15.2

138

661

SPAT1053

SPAT

Memory test

2.1

15.1

151

749

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

15.1

178

937

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

15.1

317

1984

M01AH03

ATC

valdecoxib; oral

2.1

15.0

146

718

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

14.9

241

1402

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

5.8

14.9

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

14.9

181

963

A05

ICPC

Feeling ill

1.8

14.9

221

1254

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

14.9

252

1487

UJD02

NOMESCO Finland

Gastroscopy

2.3

14.8

115

516

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.3

14.8

106

460

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

14.7

184

988

P01

ICPC

Feeling anxious/nervous/tense

1.5

14.7

510

3584

ZXE00

NOMESCO Finland

One hour or less

1.4

14.7

1114

9004

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

14.7

149

744

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

14.7

314

1974

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

14.6

269

1624

D02

ICPC

Abdominal pain epigastric

1.9

14.6

191

1041

A06AX04

ATC

linaclotide; oral

6.6

14.5

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

14.4

227

1311

WX002

NOMESCO Finland

Sedation and analgesia

1.5

14.4

429

2919

N02CC02

ATC

naratriptan; oral

2.6

14.3

303

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

6.0

14.3

B02AA02

ATC

tranexamic acid; systemic

1.5

14.3

509

3594

A01AB09

ATC

miconazole; local oral

1.8

14.3

208

1174

UDC00

NOMESCO Finland

Ear microscopy

1.9

14.2

198

1101

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

14.2

274

1675

F06.7

ICD-10 Finland

Mild cognitive disorder

3.9

14.2

106

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.6

14.2

129

N07AA02

ATC

pyridostigmine; systemic

6.2

14.2

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

14.2

153

782

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.4

14.1

389

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

14.1

123

580

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

14.1

306

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

14.1

1122

9126

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.6

14.0

ZX120

NOMESCO Finland

Intravenous

1.8

14.0

226

1316

N03AX14

ATC

levetiracetam; systemic

2.7

14.0

284

R74

ICPC

Upper respiratory infection acute

1.3

13.9

1186

9741

M24.2

ICD-10 Finland

Disorder of ligament

3.0

13.9

202

N02AC04

ATC

dextropropoxyphene; oral

2.8

13.8

235

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.0

13.8

156

811

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.7

1257

10425

H92.0

ICD-10 Finland

Otalgia

1.8

13.7

210

1203

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

13.7

152

784

M75.8

ICD-10 Finland

Other shoulder lesions

2.1

13.7

128

620

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

13.7

145

736

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

13.7

756

5792

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

13.6

813

6307

JAH01

NOMESCO Finland

Laparoscopy

2.0

13.6

158

828

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.3

13.6

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

13.6

275

1703

PA2AD

NOMESCO Finland

CT angiography of brain

4.3

13.6

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

13.5

P06

ICPC

Sleep disturbance

1.6

13.5

365

2426

XPX04

NOMESCO Finland

Angioscopy

5.5

13.5

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.1

13.5

184

R01AD01

ATC

beclometasone; nasal

1.5

13.3

459

3216

A02BA04

ATC

nizatidine; systemic

2.0

13.3

145

743

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

13.3

2187

19702

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

13.3

431

D06

ICPC

Abdominal pain localized other

1.7

13.3

272

1690

U01

ICPC

Dysuria/painful urination

1.7

13.2

237

1421

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.1

13.2

171

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

13.2

306

1963

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

13.2

294

1868

K59.0

ICD-10 Finland

Constipation

2.1

13.2

132

657

S80.0

ICD-10 Finland

Contusion of knee

1.7

13.2

237

1423

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

13.1

143

734

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.2

13.0

104

473

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

13.0

180

999

R05

ICPC

Cough

1.4

13.0

684

5187

RF420, ,

NOMESCO Finland

3.4

13.0

132

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.7

13.0

241

1458

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

13.0

119

572

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

13.0

236

1420

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.0

13.0

142

729

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

16.8

13.0

SPAT1210

SPAT

Application of cast or individual aid

2.1

13.0

118

566

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

12.9

405

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

12.9

108

501

N05AB04

ATC

prochlorperazine; systemic, rectal

3.1

12.9

168

D07AC01

ATC

betamethasone; topical

1.4

12.9

952

7630

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

12.8

152

803

WX290

NOMESCO Finland

Other blockage of nerve

1.3

12.8

1621

14033

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.4

12.7

370

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.8

12.7

101

EMB10

NOMESCO Finland

Tonsillectomy

1.7

12.7

243

1483

F05

ICPC

Visual disturbance other

2.5

12.7

328

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

12.7

129

646

SPAT1104

SPAT

Monitoring of emergency patient

1.9

12.6

152

807

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.8

12.6

230

D11

ICPC

Diarrhoea

1.5

12.6

401

2763

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

12.6

334

2211

H53.4

ICD-10 Finland

Visual field defects

3.3

12.6

145

R41.3

ICD-10 Finland

Other amnesia

3.0

12.6

192

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

12.5

2214

20061

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

130.5

12.4

J20

ICD-10 Finland

Acute bronchitis

1.6

12.4

291

1871

M77.4

ICD-10 Finland

Metatarsalgia

1.8

12.4

190

1089

SFA00

NOMESCO Finland

Small restoration

1.5

12.3

401

2775

XF405

NOMESCO Finland

Symptom ECG

5.4

12.3

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

12.3

398

2752

F48.0

ICD-10 Finland

Neurasthenia

10.5

12.2

6421

FHL

Appendicectomy

1.9

12.2

153

823

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.4

12.2

328

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

12.2

382

2622

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

12.2

212

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.9

12.1

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.6

12.1

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

12.1

392

2710

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

12.1

249

1550

N76.0

ICD-10 Finland

Acute vaginitis

1.6

12.0

287

1854

M01AX01

ATC

nabumetone; oral

2.3

11.9

400

AA1BG, ,

SPAT

2.6

11.9

260

R41.0

ICD-10 Finland

Disorientation, unspecified

3.2

11.9

150

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

11.9

244

1516

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

11.9

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.2

11.9

140

G56.4

ICD-10 Finland

Causalgia

4.8

11.9

WX704

NOMESCO Finland

Intubation

1.7

11.9

211

1262

K04.08

ICD-10 Finland

Other specified pulpit

1.6

11.9

279

1794

L13

ICPC

Hip symptom/complaint

1.5

11.9

386

2670

RF120, ,

NOMESCO Finland

3.6

11.9

106

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

11.9

265

1683

R07.0

ICD-10 Finland

Pain in throat

1.7

11.9

248

1549

RD211, ,

NOMESCO Finland

2.1

11.8

111

539

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

11.8

267

H81.4

ICD-10 Finland

Vertigo of central origin

5.4

11.8

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

11.8

121

M48.0

ICD-10 Finland

Spinal stenosis

1.8

11.8

184

1061

N06AX05

ATC

trazodone; oral

2.3

11.8

390

M25.2

ICD-10 Finland

Flail joint

3.0

11.8

167

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

11.7

161

892

-1, ,

NOMESCO Finland

1.3

11.7

1070

8816

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

11.7

128

657

K80

ICPC

Cardiac arrhythmia NOS

1.8

11.7

186

1077

N20.1

ICD-10 Finland

Calculus of ureter

2.4

11.7

347

G04BD11

ATC

fesoterodine; oral

2.9

11.7

189

I73.0

ICD-10 Finland

Raynaud syndrome

2.6

11.7

251

R25.2

ICD-10 Finland

Cramp and spasm

2.6

11.7

269

N02AJ13

ATC

tramadol and paracetamol; systemic

2.6

11.6

246

K07.61

ICD-10 Finland

Cracking jaw joint

2.3

11.6

386

PA6AD

NOMESCO Finland

CT of neck arteries

2.9

11.6

190

N05CD07

ATC

temazepam; oral

1.8

11.6

189

1104

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

11.6

821

6520

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

11.5

212

1280

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.4

11.5

118

2AB04, ,

NOMESCO Finland

8.6

11.5

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

11.5

244

1530

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

11.5

186

1084

SFA20

NOMESCO Finland

Two-surface restoration

1.3

11.4

1866

16600

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

120.4

11.4

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

11.4

657

5047

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.0

11.4

170

B01AC07

ATC

dipyridamole; systemic

4.1

11.4

N02CD01

ATC

erenumab; parenteral

3.0

11.4

165

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.0

11.4

165

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.0

11.4

130

679

P03

ICPC

Feeling depressed

1.5

11.4

367

2535

E0000UV, ,

ATC

1.3

11.3

1197

10052

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

11.3

145

786

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.4

11.3

315

J01DA06

ATC

[U] cefuroxime

1.5

11.3

392

2746

H02AB07

ATC

prednisone; oral

1.5

11.3

317

2124

R06AE09

ATC

levocetirizine; oral

1.4

11.2

473

3442

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

11.2

250

1588

R03BB04

ATC

tiotropium bromide; inhalant

1.8

11.2

168

958

132

Kela drug reimbursment

Sarcoidosis

5.6

11.2

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

11.1

226

1401

H81.0

ICD-10 Finland

Ménière disease

2.7

11.1

217

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.7

11.1

217

N06

ICPC

Sensation disturbance other

3.5

11.1

111

L02

ICPC

Back symptom/complaint

1.5

11.1

313

2100

N02CX04, ,

ATC

2.7

11.1

206

J01MA12

ATC

levofloxacin; systemic

1.5

11.1

380

2657

A07AA02

ATC

nystatin; oral

2.0

11.1

124

643

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

11.1

296

1962

N17

ICPC

Vertigo/dizziness

1.6

11.1

271

1760

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

8.1

11.1

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

11.0

1215

10252

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.2

11.0

447

FN1AD

NOMESCO Finland

CT of coronary arteries

2.9

11.0

179

M05BA07

ATC

risedronic acid; oral

3.0

11.0

163

R27.0

ICD-10 Finland

Ataxia, unspecified

10.1

11.0

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

4.7

10.9

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.1

10.9

475

N80.0

ICD-10 Finland

Endometriosis of uterus

2.2

10.9

390

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

10.9

155

869

A69.2

ICD-10 Finland

Lyme disease

1.9

10.9

147

811

WZC30

NOMESCO Finland

Teaching

1.5

10.9

355

2456

B01AC04

ATC

clopidogrel; oral

1.8

10.9

167

959

K02.1

ICD-10 Finland

Caries of dentine

1.3

10.8

1901

17014

TKD00

NOMESCO Finland

Dilatation of urethra

4.2

10.8

KMAK, ,

NOMESCO Finland

1.3

10.8

1680

14806

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

10.8

112

566

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.5

10.7

256

R06AX13

ATC

loratadine; oral

1.4

10.7

495

3659

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

10.7

347

2397

PA7CG

NOMESCO Finland

Extended MRI examination of vessesl in brain and neck with high intensity magnet

17.9

10.7

N06AB03

ATC

fluoxetine; oral

1.5

10.7

350

2424

K04

ICPC

Palpitations/awareness of heart

1.9

10.7

142

780

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

10.7

199

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

10.7

407

G04BD07

ATC

tolterodine; oral

2.2

10.7

407

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

10.7

318

Z50.1

ICD-10 Finland

Other physical therapy

2.0

10.6

118

610

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

10.6

137

745

Z2446

NOMESCO Finland

Social worker

1.7

10.6

181

1071

G01AF05

ATC

econazole; vaginal

1.6

10.6

252

1625

SPAT1283

SPAT

Restricted health certificate

1.3

10.6

720

5670

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

2.8

10.6

183

M09AX01

ATC

hyaluronic acid; parenteral

2.4

10.6

282

SPAT1360

SPAT

Extensive global examination

1.8

10.6

157

892

H15.1

ICD-10 Finland

Episcleritis

2.7

10.6

200

A02BX02

ATC

sucralfate; oral

2.3

10.6

338

R01AD05

ATC

budesonide; nasal

1.6

10.5

219

1366

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

293

228

14.05

309.30

1.1

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

610

551

13.45

307.65

1.3

1.2

382.94

488.29

mg/l

4.68

580

522

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

541

485

13.23

307.65

1.3

1.2

2027.63

9540.77

e6/l

0.48

455

389

(3044290) Cell count panel - Cerebral spinal fluid

467

463

11.65

307.65

1.3

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

534

487

12.97

307.65

1.3

1.1

3.50

3.67

mmol/l

2.94

500

456

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

312

230

14.93

307.65

1.1

1.0

210.32

227.86

mg/l

0.52

272

194

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

315

235

14.76

307.65

1.2

1.1

32.96

36.34

mg/l

0.44

262

190

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

543

485

13.29

307.65

1.3

1.2

16.83

24.63

e6/l

0.42

437

370

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

268

188

15.47

299.96

1.5

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

290

256

12.36

282.90

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

217

160

14.48

235.56

1.1

1.0

1.02

1.05

u/l

0.19

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

159

113

14.76

175.77

1.3

1.1

66.63

68.67

—

(3005719) IgG [Mass/volume] in Serum or Plasma

601

1881

3.70

161.62

2.4

2.5

10.13

10.62

g/l

2.41

542

1731

(3023410) Appearance of Cerebral spinal fluid

202

236

9.07

160.33

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

202

240

8.92

158.20

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

589

1900

3.58

150.60

2.7

2.3

28.64

23.18

au/ml

0.51

191

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

166

10.49

147.81

1.3

1.2

1.71

2.01

mmol/l

1.64

155

156

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

556

1759

3.62

146.18

1.4

1.3

49.11

48.35

au/ml

0.02

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1159

5774

2.58

133.28

2.4

1.9

119.97

218.10

u/l

3.26

1111

5474

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

144

158

9.50

119.65

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1272

7337

2.22

98.09

3.4

2.7

24.02

43.82

ng/l

1.24

584

3604

(3013826) Glucose [Moles/volume] in Serum or Plasma

1925

13170

2.16

94.59

4.6

4.1

6.08

6.40

mmol/l

12.44

1823

11991

(3024561) Albumin [Mass/volume] in Serum or Plasma

1465

9043

2.15

93.98

4.3

4.4

37.27

36.77

g/l

3.45

1390

8466

(3022217) INR in Platelet poor plasma by Coagulation assay

1394

8482

2.14

92.39

9.5

8.8

1.11

1.12

inr

0.19

450

2706

(40760892) CBC W Ordered Manual Differential panel - Blood

1794

12094

2.11

89.69

7.3

6.2

—

(3006315) Basophils [#/volume] in Blood

1870

12858

2.10

87.97

7.0

5.8

0.04

e9/l

0.03

1729

11320

(3001604) Monocytes [#/volume] in Blood

1866

12848

2.09

87.10

6.9

5.8

0.52

0.54

e9/l

3.49

1729

11329

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1579

10259

2.07

85.92

5.7

5.8

1.22

mmol/l

0.06

1351

8743

(3019198) Lymphocytes [#/volume] in Blood

1911

13335

2.08

85.25

7.0

5.8

1.90

1.97

e9/l

2.90

1792

12066

(3013115) Eosinophils [#/volume] in Blood

1906

13335

2.07

83.80

7.1

6.1

0.18

e9/l

0.20

1771

11940

(3018677) aPTT in Platelet poor plasma by Coagulation assay

621

2788

2.52

83.74

1.9

2.2

28.70

29.46

3.56

597

2692

(3013707) Erythrocyte sedimentation rate by Westergren method

2446

18880

2.27

82.09

4.8

3.7

8.49

9.77

mm/h

8.62

2340

17695

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1198

7234

2.05

77.56

2.7

2.4

53.93

57.26

u/l

2.21

1112

6726

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

11.89

77.53

1.2

1.1

16.67

23.63

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2366

18377

2.11

72.70

7.3

6.8

70.29

74.11

u/l

7.90

2256

17425

(3036481) Cortisol [Moles/volume] in Serum or Plasma

537

2427

2.46

70.40

2.2

2.0

365.22

374.60

nmol/l

0.57

505

2241

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1396

9156

1.93

69.12

5.1

5.2

1.21

1.22

mmol/l

0.28

1315

8440

(3037522) Nuclear Ab [Titer] in Serum

758

4007

2.17

68.46

1.5

1.4

495.66

561.91

titre

0.44

143

815

(3013650) Neutrophils [#/volume] in Blood by Automated count

1986

14704

1.93

67.18

8.8

8.7

3.87

3.96

e9/l

1.17

1838

12969

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1674

11762

1.89

66.11

5.1

5.6

9.36

10.28

umol/l

5.73

1589

11131

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

11.16

66.00

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

885

5097

2.02

62.79

1.4

1.3

20.57

24.64

iu/ml

0.57

273

1637

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

294

1042

3.01

61.84

2.2

2.0

39.19

39.89

u/l

0.26

279

963

(3035350) Ketones [Presence] in Urine by Test strip

1758

12726

1.85

61.35

4.5

3.1

0.00

estimate

1.28

421

2558

(3009261) Glucose [Presence] in Urine by Test strip

1771

12858

1.85

61.13

4.5

3.1

0.00

estimate

1.32

407

2420

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

7.70

60.33

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

11.05

59.99

1.2

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

969

5860

1.94

59.07

1.9

1.7

0.81

0.88

mg/l

0.42

698

4314

(3031040) Bacteria [#/volume] in Urine by Automated count

2152

16704

1.89

58.94

5.7

3.7

302.46

1247.50

e6/l

1.57

173

(3037467) Urinalysis macro (dipstick) panel - Urine

2250

17718

1.92

58.91

5.3

3.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1751

12762

1.83

58.71

5.8

4.3

0.00

estimate

0.50

414

2488

(3019069) Monocytes/100 leukocytes in Blood

1688

12182

1.82

58.33

7.3

6.1

8.17

8.11

0.42

1634

11496

(3006504) Eosinophils/100 leukocytes in Blood

1677

12098

1.81

57.83

7.0

5.8

2.82

2.80

0.16

1620

11388

(3015171) Extractable nuclear Ab [Units/volume] in Serum

306

1152

2.83

57.55

1.4

1.3

1.57

1.01

u/ml

0.25

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

8.94

57.08

1.1

31.32

359.07

ng/l

—

(3022096) Basophils/100 leukocytes in Blood

1625

11653

1.80

56.78

7.1

5.9

0.70

0.68

0.52

1558

10923

(3019550) Sodium [Moles/volume] in Serum or Plasma

2950

25933

2.84

55.29

14.7

10.5

139.77

139.61

mmol/l

4.46

2915

25239

(3015736) pH of Urine

1472

10333

1.79

54.52

4.0

2.9

6.02

5.92

0.67

142

1134

(3002030) Lymphocytes/100 leukocytes in Blood

1725

12698

1.78

54.14

7.1

5.8

29.61

29.53

0.12

1671

12020

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

8.98

54.10

1.0

789.38

760.77

ng/l

0.12

(3023103) Potassium [Moles/volume] in Serum or Plasma

2952

26031

2.80

53.61

14.7

10.6

3.90

3.92

mmol/l

3.88

2908

25274

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

8.87

53.55

1.0

331.86

298.67

ng/l

0.30

(3018010) Neutrophils/100 leukocytes in Blood

1704

12525

1.77

53.50

6.9

5.7

56.26

56.36

0.13

1651

11843

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

8.75

53.02

1.0

52.48

39.88

ng/l

0.78

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1427

10013

1.77

52.20

4.6

3.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1481

10504

1.77

52.18

2.5

2.2

77.63

74.09

nmol/l

5.27

1395

9770

(3029937) Albumin [Presence] in Urine by Test strip

1037

6661

1.83

50.85

4.9

3.4

0.01

0.00

estimate

0.28

410

2443

(3020630) Protein [Mass/volume] in Serum or Plasma

313

1272

2.62

50.52

2.0

2.4

67.90

67.76

g/l

0.14

294

1182

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

812

4841

1.91

50.35

1.4

1.3

4.52

9.70

u/ml

3.76

366

2049

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

6.83

46.70

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

9.05

46.37

2.5

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2560

21651

1.92

46.28

5.1

4.1

14.54

14.39

pmol/l

2.54

2439

20229

(3015377) Calcium [Moles/volume] in Serum or Plasma

1087

7242

1.76

46.12

2.5

3.1

2.34

2.35

mmol/l

1.92

983

6590

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

148

5.73

44.56

1.1

0.14

6.21

nmol/l

0.95

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

738

4434

1.86

43.83

1.7

1.6

31888973.18

37781099.60

pmol/l

0.11

646

3830

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2973

26757

2.64

43.43

15.5

10.5

16.42

19.95

mg/l

9.47

2422

20550

(3018418) pH of Serum or Plasma

932

6054

1.76

42.50

3.3

3.6

7.39

7.40

1.33

196

1156

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

7.33

42.39

1.1

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

163

520

3.25

40.79

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

7.01

40.70

1.2

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1186

8331

1.67

40.10

2.0

1.8

99.48

98.50

pmol/l

0.30

689

4475

(3019150) Specific gravity of Urine by Refractometry

843

5408

1.76

39.69

4.6

3.3

1.02

kg/l

0.24

114

800

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2810

24943

2.06

38.43

5.9

4.7

1.66

2.01

mu/l

2.36

2690

23553

(3048689) Calprotectin [Mass/mass] in Stool

646

3903

1.82

36.92

2.3

2.5

104.23

103.16

ug/g

0.03

500

3114

(3000850) Epithelial cells [#/volume] in Urine

723

4525

1.77

36.66

3.2

2.3

5.76

7.64

e6/l

3.55

668

4041

(3023368) Bacteria identified in Blood by Culture

768

4917

1.74

35.86

3.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3039

28009

2.81

35.55

15.5

11.2

68.83

69.86

umol/l

2.83

3039

28003

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

600

3591

1.83

35.19

3.3

2.9

108.89

495.09

ng/l

4.02

308

2139

(3002582) Erythrocytes [#/volume] in Urine

962

6573

1.66

35.15

3.8

2.8

127.70

99.10

e6/l

0.09

779

4920

(3030467) Casts [#/volume] in Urine by Automated count

894

5993

1.68

35.14

3.5

2.7

0.15

0.31

e6/l

5.11

725

4435

(3011412) CD3 cells [#/volume] in Blood

100

255

4.02

34.99

2.4

2.5

1.25

1.34

e9/l

0.48

226

(40761535) Cells panel - Urine sediment

329

1613

2.16

34.26

4.1

3.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1013

7055

1.64

34.12

1.4

1.3

1.49

1.47

u/ml

0.01

302

1993

(3044889) 12 lead EKG panel

1994

16311

1.59

33.76

3.5

2.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

308

1481

2.20

33.67

2.1

1.8

1.18

1.38

g/l

1.62

292

1372

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.99

33.25

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1494

11466

1.57

33.15

10.3

8.1

0.00

e9/l

0.99

1305

9369

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

7.86

32.77

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

510

2965

1.86

32.63

1.9

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

432

2393

1.93

32.04

6.3

5.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1049

7460

1.61

32.00

3.7

2.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.91

31.51

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

642

4050

1.73

31.04

2.4

2.7

406.67

781.35

ng/l

6.12

526

3278

(3026008) Bacteria identified in Urine by Culture

955

6689

1.61

30.79

3.4

2.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

686

4417

1.70

30.75

1.6

1.4

20.08

20.93

nmol/l

0.87

612

3920

(1175426) CD3 cells/100 lymphocytes in Blood

208

4.12

30.60

2.1

2.0

76.05

74.14

0.65

202

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

423

2362

1.91

30.55

2.6

2.2

7940.55

5434.92

u/l

0.74

147

954

(3019309) Folate [Moles/volume] in Red Blood Cells

532

3229

1.78

29.28

1.8

1.6

1210.87

1164.65

nmol/l

0.63

428

2516

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.45

29.27

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

524

3173

1.78

29.06

2.9

3.4

0.84

0.82

mmol/l

1.95

493

3004

(36304419) Bacteria [Presence] in Urine

870

6034

1.61

28.87

3.5

2.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

140

507

2.84

28.08

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1108

8166

1.55

28.07

4.6

3.2

29.79

79.06

e6/l

3.70

846

5406

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

7.27

27.98

1.1

—

(3026782) Osmolality of Urine

653

4260

1.67

27.50

3.3

2.6

542.45

539.52

mosm/kgh2o

0.12

588

3648

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

357

1949

1.94

27.45

1.8

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

10.09

27.39

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

10.09

27.39

1.1

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

360

1986

1.92

26.80

1.8

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

190

4.02

26.52

2.0

2.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

182

4.02

25.55

2.7

2.6

0.22

0.21

e9/l

0.22

154

(3008152) Bicarbonate [Moles/volume] in Arterial blood

213

986

2.24

25.43

6.0

7.3

24.39

24.28

mmol/l

0.18

203

935

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

197

883

2.31

25.39

2.0

1.16

1.18

g/l

0.28

186

831

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

166

4.16

25.28

1.1

2052.32

1475.21

miu/ml

2.71

166

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1668

13578

1.48

25.28

3.3

2.8

77.47

83.93

ug/l

1.11

1599

12848

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1513

12097

1.48

25.02

2.6

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

804

5645

1.57

24.68

4.5

3.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

8.69

24.53

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

6.92

24.18

1.1

—

(40768797) Stomach Pathology biopsy report

521

3305

1.69

24.10

1.3

1.2

—

(3013512) EKG study

789

5543

1.56

24.06

3.3

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

843

6011

1.55

24.05

1.6

1.4

2.10

2.20

g/l

1.01

594

3868

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

195

893

2.26

23.89

1.6

0.04

0.42

iu/ml

1.22

169

(3019060) Gas panel - Arterial blood

212

1005

2.19

23.87

4.3

5.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

189

855

2.29

23.83

2.0

0.23

g/l

0.15

178

806

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

188

3.84

23.64

2.7

2.6

488.36

576.11

e6/l

0.70

155

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2710

24599

1.68

23.46

4.0

3.6

5.60

5.69

mmol/l

3.26

2579

23021

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

816

5806

1.54

23.40

2.3

2.1

2.69

2.75

mg/l

0.41

730

5008

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3017

28316

2.21

23.28

11.2

8.6

25.42

25.92

u/l

0.92

2958

27524

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1139

8700

1.48

23.21

3.6

3.1

27.64

30.74

u/l

2.01

1080

8311

(3020891) Body temperature

148

613

2.48

22.75

4.9

4.5

—

(3016502) Oxygen saturation in Arterial blood

295

1629

1.89

21.76

5.7

8.4

96.59

95.95

1.22

283

1575

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2505

22441

1.54

21.52

4.5

4.4

37.30

38.01

mmol/mol

4.22

2374

21200

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

536

3533

1.62

21.11

2.9

2.4

1.00

1.23

e6/l

0.54

321

1905

(40761511) CBC panel - Blood by Automated count

3019

28483

2.12

20.65

14.4

9.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

188

903

2.15

20.47

2.1

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

989

7500

1.46

20.26

1.8

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

283

1578

1.87

20.22

4.9

3.7

5.80

5.84

kpa

0.34

277

1525

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

529

3512

1.61

20.16

2.5

2.6

2.41

2.42

mmol/l

1.19

462

3079

(3004588) Protein electrophoresis panel - Serum or Plasma

203

1013

2.07

20.00

2.2

2.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

148

652

2.33

19.86

4.4

5.9

1.64

1.67

0.09

138

609

(3047181) Lactate [Moles/volume] in Blood

133

562

2.43

19.60

4.3

6.7

1.16

1.21

mmol/l

0.27

119

495

(3007930) Methemoglobin/Hemoglobin.total in Blood

147

650

2.32

19.56

4.4

6.0

0.90

0.92

0.26

138

607

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.56

19.09

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

316

1855

1.78

19.07

5.7

7.8

12.79

13.18

kpa

0.65

305

1778

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

316

1855

1.78

19.07

5.7

7.8

4.94

5.08

kpa

2.40

303

1773

(3024354) Oxygen [Partial pressure] in Venous blood

238

1290

1.91

18.53

5.1

3.1

4.39

4.73

kpa

2.18

233

1241

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

146

660

2.27

18.46

1.4

1.2

21.10

35.17

u/ml

0.92

(3025159) Blasts/100 leukocytes in Blood

306

1801

1.77

18.28

4.6

4.4

0.06

0.48

0.87

427

(3002385) Erythrocyte distribution width [Ratio]

2618

23919

1.53

18.15

16.6

12.6

14.30

14.51

0.45

2596

23500

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2183

19276

1.42

17.98

3.5

2.8

36.73

38.34

u/l

0.58

2085

18399

(3002173) Hemoglobin [Mass/volume] in Arterial blood

271

1546

1.82

17.96

6.0

8.7

125.07

123.30

g/l

0.77

262

1504

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

177

874

2.09

17.94

1.2

—

(3003396) Base excess in Arterial blood by calculation

312

1857

1.75

17.92

5.7

7.9

1.32

0.92

mmol/l

1.27

250

1445

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

171

835

2.11

17.85

1.4

1.3

17.11

37.36

u/ml

0.90

(3002179) Metamyelocytes/100 leukocytes in Blood

306

1825

1.75

17.44

4.3

4.1

0.82

0.66

0.36

524

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

229

1251

1.89

17.40

2.3

2.0

3.76

6.68

ug/l

3.39

197

1119

(3007853) Bacteria identified in Skin by Aerobe culture

433

2832

1.61

17.38

1.8

1.6

—

(3002032) Base excess in Venous blood by calculation

272

1569

1.80

17.38

5.0

3.7

2.09

1.81

mmol/l

0.91

225

1315

(3017181) Myelocytes/100 leukocytes in Blood

324

1971

1.72

17.20

4.6

4.3

1.10

0.97

0.23

600

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

152

723

2.16

16.98

1.6

1.7

125.00

339.29

titre

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

278

1639

1.76

16.48

3.3

3.2

1.22

1.23

mmol/l

0.98

252

1411

(3022948) Iron [Moles/volume] in Serum or Plasma

491

3348

1.55

16.42

2.1

2.2

14.42

14.44

umol/l

0.01

459

3133

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2660

24517

1.51

16.34

11.8

9.1

92.12

90.97

ml/min/173m2

2.39

2292

20044

(3004789) Transferrin [Mass/volume] in Serum or Plasma

453

3039

1.57

16.27

2.1

2.2

2.50

2.45

g/l

1.17

417

2820

(21494814) CD8 cells/100 lymphocytes in Specimen

100

4.24

16.21

1.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

394

2572

1.61

15.87

1.3

1.2

109.36

160.69

iu/ml

2.25

161

1013

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

11.76

15.52

1.1

1.0

47.08

77.87

—

(3033658) Prothrombin time (PT) actual/Normal

765

5761

1.43

15.52

3.6

3.5

97.27

96.48

0.44

738

5595

(3021440) Promyelocytes/100 leukocytes in Blood

306

1890

1.68

15.32

4.7

4.3

0.13

0.01

518

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

124

570

2.22

15.11

2.0

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

414

2.44

14.99

1.5

1.7

0.63

0.73

g/l

0.50

322

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

237

1371

1.79

14.98

1.7

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

145

3.49

14.68

1.4

5.06

6.18

u/l

0.83

120

(3005322) IgE [Units/volume] in Serum or Plasma

327

2077

1.64

14.68

1.3

224.74

186.28

u/ml

0.21

301

1940

(4200892) Spirometry reversibility

262

1571

1.73

14.61

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

255

2.82

14.59

1.5

1.4

6.23

6.58

g/l

0.32

183

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

476

3306

1.52

14.50

3.1

2.6

3.32

3.75

e6/l

0.44

263

1679

(3017446) Testosterone [Moles/volume] in Serum or Plasma

242

1426

1.75

14.36

2.4

2.0

11.70

11.50

nmol/l

0.13

221

1292

(36660697) Celiac disease serology panel - Serum

378

2502

1.58

14.30

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

4.32

14.28

2.2

2.1

54.12

169.36

e6/l

2.95

(3008898) HLA-B27 [Presence]

237

1391

1.76

14.25

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

255

1529

1.73

14.22

6.4

7.1

1.25

1.29

mmol/l

0.42

248

1489

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

315

1999

1.64

14.18

3.1

4.2

218.82

237.73

u/l

2.17

299

1909

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

376

2.46

14.16

1.2

1.3

—

34.29

—

(4062490) Immunoglobulin typing, IgG

254

2.80

14.12

1.5

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

254

2.80

14.12

1.5

1.4

0.36

0.38

g/l

0.21

180

(3028192) IgG subclass 2 [Mass/volume] in Serum

254

2.80

14.12

1.5

1.4

2.83

2.94

g/l

0.18

181

(3042936) Bacteria identified in Isolate by Culture

443

3052

1.52

13.99

2.2

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

5.04

13.83

1.3

1.4

144.97

138.98

nmol/l

0.05

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

339

2.52

13.75

1.3

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

314

2007

1.63

13.73

3.2

3.4

4.49

4.56

pmol/l

0.63

281

1809

(3017143) Hepatitis C virus Ab [Presence] in Serum

572

4174

1.45

13.54

1.7

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

120

3.62

13.39

1.2

1.5

137.32

134.73

nmol/l

0.13

120

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

217

2.89

13.38

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

214

1252

1.76

13.02

1.6

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

171

936

1.87

12.94

1.1

3.17

4.29

u/ml

0.19

149

(3022145) Colonoscopy Study observation

388

2643

1.53

12.87

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

148

3.28

12.85

2.6

2.7

46.94

45.95

0.15

(3039000) Anion gap in Blood

369

2.40

12.82

5.0

8.6

10.77

11.48

mmol/l

1.19

332

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

402

2763

1.52

12.79

2.2

2.3

24.07

24.21

0.06

339

2392

(3009542) Hematocrit [Volume Fraction] of Blood

3130

30397

2.61

12.77

22.5

15.6

41.76

40.47

0.49

2982

28970

(3018572) Chloride [Moles/volume] in Blood

370

2.39

12.75

5.0

8.6

105.83

105.79

mmol/l

0.03

333

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.95

12.70

1.1

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

361

2427

1.55

12.70

4.3

5.6

1.04

1.05

mmol/l

0.17

344

2283

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

110

522

2.15

12.44

3.3

3.9

57.21

56.55

0.22

110

522

(3023323) Follitropin [Units/volume] in Serum or Plasma

362

2455

1.54

12.23

1.5

1.3

26.56

25.64

iu/l

0.20

324

2108

(3025941) Bacteria identified in Stool by Culture

270

1710

1.63

12.23

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

186

2.94

12.02

3.1

2.8

854.61

721.92

e6/l

1.08

181

(3035637) Corticotropin [Mass/volume] in Plasma

290

2.52

11.88

1.6

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.69

11.88

1.0

1.1

—

(3024731) MCV [Entitic volume]

3131

30460

2.53

11.82

22.4

15.5

90.20

90.16

0.25

3118

30157

(46235355) HIV 1 and 2 tests - Meaningful Use set

1006

8213

1.33

11.79

2.1

2.0

—

(3035941) MCH [Entitic mass]

3131

30463

2.53

11.77

22.4

15.5

30.12

30.08

0.77

3118

30158

(3010813) Leukocytes [#/volume] in Blood

3131

30467

2.52

11.69

22.5

15.6

6.57

6.67

e9/l

1.86

3098

29797

(3026361) Erythrocytes [#/volume] in Blood

3131

30467

2.52

11.69

22.5

15.5

4.52

4.53

e12/l

0.25

3099

29813

(40758558) Short blood count panel - Blood

795

6282

1.35

11.58

6.2

6.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

197

1166

1.73

11.52

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

3131

30478

2.50

11.48

22.6

15.6

135.73

135.55

g/l

0.35

3118

30162

(3007461) Platelets [#/volume] in Blood

3128

30438

2.45

11.44

22.6

15.6

264.26

263.05

e9/l

0.54

3102

29832

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

424

3012

1.47

11.42

2.2

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

142

764

1.90

11.36

1.4

1.3

3.76

6.51

u/ml

0.63

117

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

140

751

1.90

11.30

1.4

1.3

3.38

3.37

u/ml

0.00

(3009214) Lutropin [Units/volume] in Serum or Plasma

192

1135

1.74

11.28

1.4

1.3

11.67

10.05

u/l

0.76

163

938

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

159

893

1.82

11.12

6.6

10.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2419

22346

1.34

11.02

4.2

3.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

132

3.21

10.95

2.7

2.9

567.45

829.87

u/ml

0.85

132

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

272

1777

1.58

10.83

2.2

80.21

76.43

ml/min/173m2

0.99

107

670

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

354

2.29

10.77

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

305

2048

1.54

10.76

3.5

2.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

164

941

1.78

10.69

1.4

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

201

1222

1.69

10.67

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

702

5528

1.35

10.29

2.2

2.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

108

3.36

10.12

1.3

125.67

156.91

mmol/24h

1.89

108

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

190

1156

1.68

10.07

2.3

2.6

90.48

131.90

ng/l

0.91

167

1030

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

179

1072

1.71

10.06

2.9

3.3

1.31

1.59

mmol/l

0.55

125

796

(3026493) Urate [Moles/volume] in Serum or Plasma

731

5823

1.33

9.86

2.2

2522.74

3276.26

umol/l

0.31

662

5267

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

197

2.67

9.77

1.2

1.03

1.04

ratio

0.04

(3009343) pH of Capillary blood

182

1104

1.69

9.76

3.0

3.3

7.41

0.27

141

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.79

9.76

1.7

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

183

1115

1.68

9.66

3.0

3.3

5.12

5.15

kpa

0.21

176

1072

(3000570) Elastase.pancreatic [Mass/mass] in Stool

111

582

1.94

9.64

1.5

1.3

333.96

308.55

ug/g

0.51

287

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.80

9.53

1.0

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

132

737

1.83

9.45

1.4

18.88

23.35

u/l

1.06

112

620

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.70

9.42

3.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

109

580

1.91

9.08

1.4

1.2

2.42

3.45

u/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

304

2.26

8.99

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

218

2.50

8.95

1.3

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

311

2.25

8.95

1.3

0.14

0.56

nmol/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

256

1725

1.53

8.89

1.6

324.20

298.38

mu/l

0.38

230

1543

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.25

8.65

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

239

1597

1.54

8.63

1.2

1.1

104.00

120.92

titre

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

761

6199

1.30

8.57

2.3

2.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

503

3880

1.35

8.29

1.6

1.8

1.36

1.37

0.13

446

3506

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

472

1.96

8.21

1.6

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

364

2.09

8.12

1.5

1.3

9.78

38.34

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

109

3.05

8.00

1.2

1.1

—

(3012501) Base excess in Blood by calculation

422

1.99

7.93

3.6

3.3

2.16

2.39

mmol/l

0.37

265

(3017732) Neutrophils [#/volume] in Blood

270

1885

1.47

7.90

2.1

2.4

4.04

5.05

e9/l

1.68

236

1641

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

3.07

7.85

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

473

1.93

7.83

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

920

7753

1.26

7.77

2.3

2.0

—

(40761536) Microorganisms panel - Urine sediment

318

2301

1.42

7.70

5.0

3.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.34

7.68

2.3

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

812

6758

1.27

7.59

1.7

—

(4034850) Laboratory test

130

774

1.71

7.54

8.0

7.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

424

1.96

7.49

1.8

2.0

5.03

5.20

mmol/24h

0.19

385

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

186

1217

1.56

7.40

1.1

1.14

3.26

u/ml

—

(3023419) Bacteria identified in Sputum by Culture

234

2.29

7.29

2.5

3.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

494

3872

1.33

7.26

2.3

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

479

1.88

7.24

2.4

5.7

1820.60

600.73

iu/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

114

662

1.75

7.23

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

301

2.12

7.15

1.8

1.5

38.46

49.76

mu/l

0.45

270

(3036489) Thrombin time

149

934

1.62

7.11

2.0

22.35

21.12

0.58

112

788

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

104

591

1.79

7.11

2.1

2.0

0.64

2.00

ug/l

1.82

536

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2609

24770

1.29

7.08

3.5

3.3

1.25

mmol/l

0.06

2464

23421

(3003327) Ova and parasites identified in Stool by Light microscopy

165

1064

1.58

7.01

1.9

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

470

1.87

7.00

1.2

10.90

3.72

u/ml

0.62

151

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

253

2.19

6.88

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

129

791

1.66

6.73

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

206

2.30

6.60

1.4

1.5

288.18

283.41

mosm/kgh2o

1.09

158

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

127

782

1.65

6.53

1.3

1.5

0.41

0.46

nmol/l

0.31

106

643

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

280

2.09

6.45

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

127

785

1.64

6.44

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

106

627

1.71

6.35

1.2

224.65

264.83

u/ml

0.99

407

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

575

1.74

6.32

2.2

2.4

260.18

408.27

ug/l

0.55

527

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

576

1.74

6.29

1.8

1.6

—

(1616796) Gas panel - Central venous blood

401

1.89

6.27

3.5

2.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.02

6.21

1.1

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

541

1.76

6.20

2.2

2.0

2.57

2.97

g/l

3.69

506

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

564

1.74

6.18

2.2

2.0

6.91

7.34

g/l

2.01

529

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

335

1.96

6.07

1.5

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

335

1.96

6.07

1.5

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

125

782

1.62

6.06

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

261

2.09

6.01

1.4

1.6

—

(3045424) Erythrocytes [Presence] in Urine

407

1.86

6.01

1.4

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.02

5.99

1.1

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

282

2.04

5.96

1.6

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

519

1.76

5.92

2.3

2.0

10.00

10.54

g/l

0.48

482

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

564

1.72

5.91

2.2

2.0

3.61

3.63

g/l

0.05

529

(3009508) Creatinine [Moles/volume] in Urine

744

6289

1.24

5.87

3.3

7.78

7.89

mmol/l

0.24

646

5512

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

382

1.88

5.85

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

382

1.88

5.85

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

285

2.02

5.81

1.6

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

501

1.76

5.76

1.4

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

280

2.02

5.71

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

481

1.77

5.67

2.6

2.8

—

(3045414) Leukocytes [Presence] in Urine

165

1118

1.50

5.66

1.6

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

564

1.71

5.65

2.2

2.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

288

2.00

5.65

1.5

1.4

336.28

366.20

pmol/l

0.23

257

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

460

1.78

5.63

1.3

—

(3000991) Gas panel - Venous blood

208

1477

1.44

5.62

8.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

490

1.75

5.61

2.3

2.2

0.98

0.70

g/l

0.35

451

(3019225) pH of Specimen

262

1940

1.38

5.57

3.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

147

976

1.53

5.55

1.6

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2719

26125

1.28

5.54

4.2

3.9

2.90

2.91

mmol/l

0.01

2567

24746

(3027945) Reticulocytes/100 erythrocytes in Blood

253

1867

1.39

5.50

2.2

2.7

1.62

1.74

1.26

232

1672

(3025468) Yersinia sp identified in Specimen by Organism specific culture

278

2.00

5.46

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

279

1.99

5.41

1.6

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

188

1320

1.45

5.41

2.0

2.7

70.14

72.50

e9/l

0.36

143

955

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

214

1539

1.42

5.40

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2695

25888

1.26

5.36

3.9

3.6

4.80

4.82

mmol/l

0.54

2556

24648

(3005988) Vibrio sp identified in Specimen by Organism specific culture

280

1.98

5.36

1.6

1.4

—

(40768804) Tissue Pathology biopsy report

1205

10768

1.19

5.26

2.0

1.9

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.99

5.25

1.0

1.1

92.68

92.86

0.01

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.69

5.17

1.2

1.3

77.92

88.49

nmol/24h

0.29

(3042631) Mycobacterium sp identified in Specimen

196

2.16

5.16

1.9

2.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

377

1.82

5.14

1.2

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

198

1418

1.42

5.13

2.6

3.7

60.11

75.47

ng/l

5.51

178

1275

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

223

1634

1.39

5.07

2.1

1.8

—

(3000494) Fungus identified in Specimen by Culture

370

2930

1.30

5.01

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

801

6920

1.21

5.00

1.6

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

163

1132

1.46

4.99

7.6

7.3

24.97

24.78

mmol/l

0.32

163

1127

(3049717) Cytology report of Urine Cyto stain

471

1.72

4.95

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2680

25781

1.25

4.91

3.9

3.6

1.49

1.50

mmol/l

0.61

2538

24472

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

346

2733

1.30

4.78

2.3

2.7

6.07

6.55

umol/l

0.25

294

2347

(40767503) Oxygen content in Capillary blood by calculation

372

1.79

4.76

2.8

2.2

17.98

16.67

2.38

181

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

138

2.33

4.75

1.4

2.51

2.86

nmol/l

0.10

102

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

118

776

1.54

4.71

3.9

2.6

3.25

3.57

g/l

2.51

109

734

(3022313) Gas panel - Capillary blood

123

818

1.52

4.67

3.2

3.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

472

1.69

4.66

4.2

3.1

23.86

22.18

mg/l

0.16

295

(3037121) Protein [Mass/volume] in Urine

110

717

1.55

4.58

3.6

3.2

0.19

0.34

g/l

1.03

307

(43055514) Macroprolactin [Presence] in Serum or Plasma

117

2.41

4.47

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.77

4.44

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

410

3342

1.26

4.40

4.3

3.8

1.86

2.19

ug/l

0.32

375

3051

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

240

1822

1.34

4.40

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

550

1.62

4.38

1.2

1.1

10.30

13.17

au/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

122

822

1.50

4.37

2.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

197

2.04

4.33

1.4

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.01

4.31

1.1

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.01

4.31

1.1

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

6.27

4.29

1.0

1.1

—

(3000492) Spirometry study

352

2827

1.28

4.28

1.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

621

5310

1.21

4.25

1.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

182

1331

1.39

4.23

2.1

2.0

—

(3011288) Drugs identified in Urine by Screen method

172

1247

1.40

4.21

3.5

3.1

—

(3021901) Oxygen saturation in Capillary blood

284

1.84

4.19

2.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

448

1.67

4.19

2.1

2.0

40.32

38.46

g/l

2.06

413

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.27

4.18

1.1

0.61

0.70

umol/24h

—

(3024869) Neuronal Ab [Presence] in Serum

4.81

4.18

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

449

1.66

4.16

2.1

2.0

0.02

0.01

g/l

0.06

426

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

336

1.77

4.16

1.5

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.60

4.13

1.5

10.91

12.97

u/l

0.88

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

202

1.99

4.06

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

331

1.77

4.06

1.8

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

187

1385

1.37

4.04

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

236

1815

1.32

3.99

1.3

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

105

2.39

3.97

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

5.57

3.97

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

225

1.92

3.96

1.3

1.2

1.71

1.25

u/ml

0.18

109

(3016879) Cocaine [Presence] in Urine

218

1663

1.33

3.90

2.4

2.2

—

(3012516) Albumin [Mass/volume] in Urine

605

5203

1.20

3.88

3.1

3.3

1594.32

300.42

mg/l

2.36

339

3329

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

337

1.73

3.84

1.1

1.2

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.28

3.82

1.9

1.7

0.83

1.94

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.28

3.82

1.9

1.7

1.14

3.90

mg/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

121

839

1.46

3.81

2.1

97.36

94.05

0.98

107

802

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

146

2.13

3.80

1.0

1.1

88.83

91.18

0.20

114

(1001926) Buprenorphine [Presence] in Urine by Screen method

187

1401

1.36

3.78

2.6

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

596

1.54

3.77

1.1

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

154

1120

1.39

3.74

1.6

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

378

1.68

3.73

1.5

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

128

2.20

3.70

1.2

0.32

0.28

g/l

1.20

101

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

238

1.86

3.69

1.6

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

238

1.86

3.69

1.6

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

113

781

1.46

3.63

2.6

2.3

159.81

169.90

0.79

105

739

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

110

2.28

3.61

1.2

1.1

95.14

99.50

0.22

(40768443) Skin Pathology biopsy report

133

949

1.42

3.61

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

108

741

1.47

3.61

1.2

1.3

442.50

127.08

titre

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

233

1.86

3.60

1.4

1.7

58.96

55.94

0.17

153

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

170

2.01

3.59

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

170

2.01

3.59

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

170

2.01

3.59

1.4

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

662

5777

1.18

3.59

2.3

2.0

—

(3037756) Immunofixation for Serum or Plasma

263

1.80

3.56

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.77

3.55

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.77

3.55

1.9

1.8

1.28

0.70

mg/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

164

2.02

3.54

1.2

1.1

6.57

32.36

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

501

1.57

3.54

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

464

1.59

3.47

1.2

1.3

5.69

3.85

u/ml

0.30

188

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

159

2.02

3.44

2.8

3.0

37722.17

39795.49

ug/l

0.43

159

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

139

2.10

3.43

1.5

2.1

1.54

2.14

u/field

0.47

(3006184) Hemoglobin [Mass/volume] in Capillary blood

403

1.63

3.42

2.3

2.2

136.56

131.49

g/l

1.16

304

(3020779) Urea [Moles/volume] in Serum or Plasma

195

1494

1.33

3.42

4.9

7.7

6.36

7.71

mmol/l

3.31

186

1442

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

141

1027

1.39

3.42

2.3

2.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.99

3.41

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

239

1.81

3.34

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

106

737

1.45

3.33

3.4

3.3

24.82

24.78

mmol/l

0.06

100

692

(3004616) Nuclear Ab [Presence] in Serum

329

1.68

3.33

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.93

3.29

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

190

1.90

3.29

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

115

2.18

3.28

1.2

1.1

96.31

94.43

0.14

(3028707) Methadone [Presence] in Urine by Screen method

110

773

1.44

3.28

3.4

3.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

416

1.60

3.27

2.3

2.0

0.00

g/l

-0.00

395

(3020682) Albumin/Creatinine [Ratio] in Urine

623

5451

1.18

3.25

3.6

3.9

5.54

9.58

mg/mmol

2.37

355

3510

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

205

1.86

3.25

1.1

4.19

9.47

iu/ml

1.54

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

443

3761

1.21

3.25

1.8

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

417

1.60

3.24

2.3

2.5

—

(3028300) Cannabinoids [Presence] in Urine

230

1817

1.29

3.23

2.4

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

228

1800

1.29

3.22

2.4

2.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

418

1.59

3.21

2.3

2.0

0.01

0.00

g/l

0.49

396

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

105

735

1.44

3.20

1.9

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

323

2660

1.24

3.20

3.8

3.3

21.45

21.42

0.01

125

1009

(3027008) Opiates [Presence] in Urine

229

1812

1.28

3.18

2.4

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

349

1.64

3.17

1.4

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

493

1.53

3.12

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

105

2.20

3.09

1.4

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

314

1.67

3.06

2.3

—

(3027944) Amphetamines [Presence] in Urine

225

1786

1.28

3.06

2.3

2.1

—

(3022621) pH of Urine by Test strip

203

1591

1.29

3.05

2.7

2.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

106

2.18

3.02

1.1

—

(3003181) Sodium [Moles/volume] in Urine

240

1.76

3.01

1.2

1.5

85.49

66.72

mmol/l

1.41

204

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.24

2.96

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

623

1.46

2.94

1.5

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

558

1.48

2.92

1.1

1.4

94.04

105.27

u/ml

0.65

123

(3021879) Hepatitis B virus core Ab [Presence] in Serum

327

2725

1.22

2.91

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

610

1.46

2.86

1.2

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

2.65

2.79

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.65

2.79

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.65

2.79

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.65

2.79

1.3

1.1

—

(3004451) EKG impression Narrative

2.47

2.78

1.7

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.01

2.72

2.3

4.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

709

1.41

2.71

2.0

2.2

4.59

4.78

umol/l

0.13

526

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.70

1.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.70

1.4

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.18

2.67

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

129

1693

0.75

2.60

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

361

1.56

2.59

2.6

3.1

34.90

34.09

umol/l

0.08

339

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.61

2.57

1.1

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.01

2.56

2.3

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

231

1885

1.24

2.53

2.3

0.23

g/l

0.86

219

1777

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

271

2250

1.22

2.53

2.9

2.3

33.03

57.85

u/l

0.62

233

1951

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

130

1695

0.76

2.51

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.33

2.48

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

131

1702

0.76

2.47

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.38

2.47

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

131

1701

0.76

2.46

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

144

1.88

2.46

1.6

1.7

—

(3028433) Virus identified in Specimen by Culture

2.29

2.41

1.2

—

(3021788) Differential panel - Synovial fluid

368

1.53

2.40

1.6

—

(3044927) Protein electrophoresis panel - Urine

131

1.92

2.40

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

108

805

1.35

2.37

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.26

2.37

1.2

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

205

1.72

2.37

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

139

1.88

2.36

1.8

1.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

108

1429

0.75

2.34

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

229

1.67

2.33

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

229

1.67

2.33

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

229

1.67

2.33

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

207

1.70

2.30

2.0

1.6

1.28

1.25

promille

0.04

166

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

207

1.70

2.30

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.56

2.27

1.1

1.3

411.14

318.83

pmol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

105

1388

0.75

2.27

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

231

1.65

2.26

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

231

1.65

2.26

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

270

1.60

2.26

1.4

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

106

1.99

2.25

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

232

1.65

2.23

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

194

1.71

2.22

1.7

2.1

33.97

32.39

1.73

194

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

121

1.91

2.20

3.3

3.0

105.63

193.99

umol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

187

1.72

2.20

2.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

450

1.45

2.20

1.0

1.1

126.64

117.80

1.95

408

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

190

1544

1.25

2.20

1.4

1.3

198.70

235.70

miu/ml

0.80

800

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

107

807

1.34

2.20

1.9

2.1

2.69

4.35

iu/l

4.44

320

(3005033) Fetal Nuchal fold Thickness US

105

1381

0.75

2.20

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

543

1.41

2.18

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

505

4487

1.15

2.15

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

147

1842

0.79

2.13

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

389

1.47

2.09

3.8

3.2

23.47

71.98

mg/l

1.73

306

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.14

2.08

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.14

2.08

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.71

2.07

1.0

12.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.71

2.07

2.0

2.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

465

1.43

2.06

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

526

1.40

2.01

1.1

1.48

3.09

u/ml

2.11

285

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

378

1.46

1.96

3.7

3.2

1.14

1.78

ratio

—

(3052851) Hemolysis interference index of Serum or Plasma

641

1.35

1.94

3.0

2.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

389

1.45

1.90

3.8

3.2

29.12

38.21

mg/l

0.45

308

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

196

1.64

1.89

1.2

—

20.00

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

168

1374

1.24

1.88

1.8

1.7

4.48

4.34

mg/l

0.04

134

980

(3038177) Helicobacter pylori Ab [Presence] in Serum

551

1.37

1.87

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

213

1.60

1.85

1.6

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

675

6172

1.12

1.83

1.7

1.6

1.42

1.38

mmol/l

0.54

593

5353

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

137

1.76

1.83

2.1

2.9

146.81

48.65

au/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

185

1534

1.22

1.82

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

101

1.89

1.80

1.4

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

296

2564

1.17

1.80

3.8

3.5

31.99

31.83

0.09

228

1900

(3028717) Thiamine [Mass/volume] in Blood

2.76

1.79

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

428

1.41

1.79

3.9

3.4

—

(3003338) MCHC [Mass/volume]

2499

24383

1.12

1.79

18.5

13.1

333.27

332.75

g/l

2.26

2488

24210

(3004716) Salmonella sp identified in Stool by Organism specific culture

219

1850

1.20

1.78

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.35

1.77

2.8

5.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

102

1.87

1.76

1.4

1.7

—

(3017569) Oxygen content in Arterial blood

2.09

1.76

3.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

456

1.39

1.73

1.6

1.7

18867.86

9557.41

e6/l

0.54

328

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.92

1.72

1.3

1.2

40.80

113.46

ng/l

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

348

1.44

1.71

4.6

6.0

347.44

380.42

umol/l

0.89

311

(1002224) Polysomnography panel

168

1390

1.22

1.71

1.1

—

(3051651) Icteric interference index of Serum or Plasma

126

1.75

1.67

5.1

3.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

180

1.62

1.66

1.4

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.1

—

(3017704) Immunofixation for Urine

2.03

1.64

1.6

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

2.44

1.64

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

504

1.36

1.64

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

294

1.47

1.62

3.5

3.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

213

1.56

1.62

1.2

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

1.75

1.62

1.5

1.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.58

1.61

1.0

1.1

—

0.07

—

(3032057) Clostridioides difficile [Presence] in Stool

2.50

1.59

1.9

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

214

1.55

1.59

1.6

1.9

22.80

23.79

mg/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.00

1.58

1.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

2.28

1.55

1.6

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

449

1.37

1.55

1.3

1.1

14.65

19352.21

iu/ml

0.56

125

(3006462) Nitrate [Presence] in Urine

107

1.78

1.54

3.2

2.6

—

(3044941) Cell count panel - Synovial fluid

306

1.44

1.54

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

208

1.54

3.8

6.2

6.69

6.95

mmol/l

0.19

177

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.60

1.51

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

185

1.57

1.51

3.2

3.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

193

1.56

1.51

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.16

1.50

1.8

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

524

0.68

1.48

1.0

1.48

0.30

u/ml

—

146

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.44

1.47

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

147

1.64

1.47

2.7

3.5

8.79

7.68

mg/l

0.35

120

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.81

1.47

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.23

1.46

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

2.23

1.46

6.8

2.3

—

(3051101) Glucose [Moles/volume] in Cord blood

2.73

1.43

3.2

5.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.73

1.43

2.2

3.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

212

1.51

1.43

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.31

1.43

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

329

1.40

3.8

4.4

153.19

75.24

u/ml

0.41

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.42

1.39

1.1

1.2

1.37

1.66

umol/24h

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

230

1.48

1.39

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

373

4137

0.89

1.37

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

174

1.56

1.37

2.2

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.83

1.35

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.83

1.35

1.5

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

143

1.61

1.35

1.3

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

167

1.56

1.34

1.6

25.29

35.45

0.76

103

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.97

1.32

1.0

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.81

1.31

1.5

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

259

1.43

1.29

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.36

1.29

1.1

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.78

1.28

4.2

1.6

334.20

326.78

umol/24h

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

0.45

1.28

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.05

1.26

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.40

1.24

1.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

512

1.30

1.23

1.2

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

171

1.52

1.23

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.63

1.21

2.4

2.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.63

1.21

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.17

1.21

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

116

1.64

1.21

1.5

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

331

1.36

1.20

1.4

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.31

1.18

2.3

3.9

40.17

42.66

umol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

290

1.38

1.17

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

149

1.55

1.17

2.6

3.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

182

1.49

1.15

2.6

2.0

—

(3000330) Specific gravity of Urine by Test strip

120

1007

1.20

1.14

3.3

2.8

—

(3051611) Lipemic interference index of Serum or Plasma

191

1.47

1.13

4.6

2.6

—

(3047189) Immunofixation for 24 hour Urine

1.85

1.13

2.0

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

727

1.23

1.11

1.7

2.0

1.40

g/l

0.00

642

(44813793) Dust mix specific IgE antibody measurement

234

1.41

1.10

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

311

1.36

1.10

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

739

0.78

1.09

1.1

0.21

1.18

u/ml

3.20

323

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

355

1.33

1.08

1.1

1.41

1.46

g/l

0.33

324

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

120

1.59

1.08

7.8

7.5

1965.00

118.78

u/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

210

1.43

1.08

3.2

3.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.76

1.06

1.3

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

192

0.57

1.05

1.2

1.5

—

(3025130) Human papilloma virus identified in Specimen

646

0.77

1.05

1.7

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

734

0.79

1.04

1.1

0.98

1.69

u/ml

0.86

361

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.96

1.03

1.3

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

438

1.28

1.02

2.4

3.4

0.33

u/ml

0.04

234

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

223

1986

1.13

1.01

2.5

0.59

0.70

ug/l

2.04

127

1117

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

188

1.44

1.01

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

180

1.45

1.00

1.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

485

1.26

0.99

1.1

—

(3024928) Oxygen saturation in Venous blood

361

1.31

0.99

9.6

3.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

181

1.44

0.98

5.5

7.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

199

0.60

0.96

1.5

4.78

5.39

mmol/l

2.62

193

(3045683) HLA typing for celiac disease panel - Blood or Tissue

224

1.39

0.96

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

231

0.65

0.90

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

324

1.30

0.88

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

168

1488

1.14

0.86

1.5

—

(3002256) Pathology report gross observation

348

3211

1.09

0.85

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

424

1.25

0.85

2.5

2.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.94

0.84

1.2

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

274

1.32

0.83

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.76

0.83

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

327

1.29

0.83

1.1

104.06

96.25

1.87

307

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

113

1.51

0.82

1.1

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

138

1.45

0.81

1.3

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

186

1668

1.12

0.80

2.0

2.6

18.23

40.87

u/ml

6.01

177

1617

(3023430) Cat dander IgE Ab [Units/volume] in Serum

586

0.80

0.79

1.0

1.1

4.54

4.16

u/ml

0.06

240

(3008536) Aspergillus sp Ab [Presence] in Serum

1.82

0.79

1.3

2.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

173

1.39

0.78

1.9

2.9

—

(3014051) Protein [Presence] in Urine by Test strip

622

1.19

0.76

2.3

2.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

485

1.22

0.76

1.5

2.5

0.98

0.85

nmol/l

0.62

423

(3020876) Protein [Mass/time] in 24 hour Urine

183

1.37

0.75

2.5

1.30

1.40

g/24h

0.08

(40765096) Chromosome analysis panel by Banding

1.64

0.73

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

254

1.30

0.73

1.1

1.4

—

titre

—

(3000012) Reticulocyte production index

194

1.34

0.71

1.8

2.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.92

0.70

1.4

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.92

0.70

2.4

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

781

0.84

0.69

1.1

6.45

6.50

u/ml

0.01

431

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.85

0.68

3.4

7.6

21.80

25.12

ug/min

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.85

0.68

1.0

2.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.67

0.68

1.4

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

110

1.46

0.68

1.3

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

258

1.28

0.67

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.63

0.66

1.0

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.79

0.66

1.0

1.2

—

2.45

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

155

0.64

0.65

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

903

8707

1.05

0.64

1.8

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

133

1189

1.12

0.64

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.48

0.64

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.73

0.64

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

207

1.31

0.63

1.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.52

0.62

2.8

3.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.63

0.62

1.3

—

(3019174) dRVVT (LA screen)

1.67

0.61

1.4

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.60

0.0

1.0

—

26.94

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

157

1.34

0.59

1.6

1.4

137.53

219.06

pmol/l

0.71

157

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

237

1.27

0.58

1.8

2.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

123

1.38

0.57

1.1

1.4

34489.00

79379.27

e6/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

328

3484

0.93

0.55

1.6

—

(4035726) Immunohistochemistry procedure

172

1874

0.91

0.55

1.3

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

385

1.20

0.54

1.2

1.3

—

(21494434) Karyotype in Bone marrow

142

1.34

0.54

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.47

0.54

3.0

2.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

205

1.27

0.52

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

746

0.87

0.51

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

198

1.26

0.49

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.40

0.48

1.5

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

111

0.63

0.48

35.4

36.5

7.41

7.31

ug/l

—

103

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

623

0.86

0.47

1.3

1.2

—

(40768441) Liver Pathology biopsy report

188

0.74

0.46

1.2

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

200

1.25

0.46

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.37

0.44

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

629

0.87

0.43

1.1

6.00

3.54

u/ml

0.43

296

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.61

0.43

1.4

2.4

4.72

3.49

mg/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

651

1.12

0.42

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

249

1.21

0.41

1.1

—

(40768795) Lymph node Pathology biopsy report

217

0.78

0.41

1.1

1.2

—

(4212803) Bone marrow aspirate examination

0.00

0.41

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

652

1.12

0.41

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

22.49

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3035880) pH of Pleural fluid

1.36

0.41

1.0

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.40

0.0

6.7

—

7.37

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.39

0.40

1.1

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.40

0.0

1.3

—

8.00

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.31

0.39

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.31

0.39

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.31

0.39

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

104

1131

0.92

0.36

1.5

1.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.64

0.35

1.0

—

4.60

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

423

1.14

0.35

1.7

1.5

—

(40768793) Breast Pathology biopsy report

699

1.10

0.34

1.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

330

0.85

0.34

1.4

1.6

—

(40758292) HTLV I+II Ab panel - Serum

1.33

0.33

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

228

1.19

0.33

1.5

1.02

0.97

g/l

0.34

228

(3020650) Glucose [Presence] in Urine

1.33

0.32

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

549

0.89

0.31

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

183

1.20

0.31

1.6

1.5

1.35

1.49

nmol/l

0.28

168

(3009871) Measles virus Ab [Titer] in Serum

110

1.27

0.31

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

860

0.92

0.30

1.1

1.21

2.56

u/ml

1.90

440

(3050129) First trimester maternal screen panel - Serum or Plasma

221

2106

1.05

0.30

1.5

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.27

0.30

1.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

102

1.28

0.30

1.2

1.3

445.76

334.59

u/l

0.38

(3041806) Other cells [#/volume] in Blood by Manual count

206

0.82

0.29

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.23

0.29

1.1

3.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.23

0.29

1.1

3.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

164

1731

0.94

0.28

3.0

4.1

3.03

37.92

ug/l

1.04

119

1309

(3011897) Casein IgE Ab [Units/volume] in Serum

1.29

0.28

1.3

1.1

0.01

0.28

u/ml

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

806

1.08

0.28

1.4

52.62

107.97

pmol/l

2.01

789

(3011648) Oxygen content in Venous blood

140

1.22

0.27

2.7

3.1

11.63

11.31

0.15

140

(3042111) Morphology [Interpretation] in Bone marrow Narrative

271

1.15

0.27

1.9

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.19

0.26

1.8

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.69

0.26

10.0

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.69

0.26

5.2

2.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.25

0.25

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.20

0.25

1.3

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.20

0.25

3.3

2.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.20

0.25

1.8

2.2

11.26

16.21

umol/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

226

1.15

0.25

1.3

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

147

0.82

0.23

1.1

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.25

0.22

1.2

—

221.60

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

233

2417

0.96

0.22

1.3

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

2.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

181.73

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

21.27

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.9

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

8.6

—

148.00

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.0

—

(40758358) Immune stain study

0.00

0.20

0.0

1.0

—

(1761868) Lipid panel - Serum or Plasma

1121

11070

1.02

0.20

2.4

2.3

—

(3002619) Bacteria identified in Specimen by Culture

1.18

0.19

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

203

1.13

0.19

1.0

1.3

—

250.00

—

(3003434) Protein [Mass/volume] in Pleural fluid

147

1.16

0.18

1.4

38.89

35.09

g/l

0.67

132

(40768806) Pleura Pathology biopsy report

131

0.84

0.17

1.4

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.76

0.15

3.2

2.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.15

0.15

1.1

1.2

17.44

11.59

u/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

234

2403

0.97

0.15

1.6

1.7

—

(3024932) HLA-DR beta [Type]

0.81

0.14

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

217

1.11

0.14

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

131

1.15

0.14

1.0

11.21

12.12

u/ml

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

209

1.10

0.13

1.3

1.61

1.57

g/l

0.37

209

(3036071) Salmonella sp Ab [Titer] in Serum

124

1.13

0.11

1.0

1.1

—

(3034426) Prothrombin time (PT)

105

1.14

0.11

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.11

0.09

1.0

—

8.11

—

(40768800) Prostate Pathology biopsy report

166

0.90

0.09

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

315

3195

0.98

0.08

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.03

0.08

4.0

1.7

14.40

57.29

u/l

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

137

1.10

0.07

1.3

1.7

—

1131948.46

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.83

0.07

1.0

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.83

0.07

1.0

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

600

1.03

0.07

2.5

3.7

828.77

432.07

u/ml

0.21

504

(3024471) HLA-A [Type]

1.05

0.07

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.03

0.07

2.1

1.4

9.22

8.08

ug/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

167

1.08

0.06

1.4

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

759

1.03

0.06

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

168

1.07

0.06

1.4

39398.89

68920.49

e6/l

—

115

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

139

1.08

0.05

1.2

1.5

15.29

5.66

u/l

—

117

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.10

0.04

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

170

1.06

0.04

2.8

3.3

123.00

37.89

mg/l

0.41

121

(3020874) Milk IgE Ab [Units/volume] in Serum

260

1.04

0.03

1.1

1.0

0.42

2.49

u/ml

0.92

(3014599) Egg white IgE Ab [Units/volume] in Serum

270

1.04

0.03

1.1

1.0

0.41

0.67

u/ml

0.48

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

421

0.97

0.03

2.5

2.4

65.87

100.35

ug/min

0.40

267

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

181

1.05

0.03

1.6

1.9

—

(3012441) Differential panel - Pleural fluid

122

1.07

0.02

1.2

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

247

0.97

0.01

1.0

0.10

1.55

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

777

0.99

0.01

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

807

0.99

0.01

1.5

1.3

4.71

4.03

ug/l

0.16

751

(3045788) Cell count panel - Pleural fluid

106

0.94

0.01

1.2

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

114

1.05

0.00

1.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

144

1.04

0.00

1.7

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

196

0.97

0.00

1.1

—

(3016750) Collection duration of Urine

105

0.95

0.00

1.5

2.4

500.70

510.64

min

—

(3035933) Granulocytes/100 leukocytes in Blood

115

0.96

0.00

1.1

1.3

—

(4146454) Self-monitoring of blood glucose

155

0.97

0.00

2.7

2.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

165

0.97

0.00

2.9

3.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

129

1.01

0.00

1.2

1.3

6.00

6.36

mmol/l

0.22

117

(4281824) Cell count and differential, peritoneal fluid

265

0.98

0.00

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

198

1.01

0.00

1.3

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

123

0.98

0.00

1.1

0.28

10.70

u/ml

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3014271) Vancomycin [Susceptibility]

1.02

0.00

2.2

2.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.90

-0.00

3.3

2.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.00

-0.00

1.0

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

2.21

—

(40768446) Kidney Pathology biopsy report

0.94

-0.00

1.1

1.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.91

-0.00

1.0

82.42

73.17

ug/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.3

—

0.22

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3024263) Appearance of Synovial fluid

0.92

-0.00

1.3

1.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.02

-0.00

1.2

2.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.94

-0.00

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

180

1.00

-0.00

1.3

69.28

73.56

umol/l

0.52

180

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3033799) Differential panel - Peritoneal fluid

1.00

-0.00

1.0

2.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_POSTOPNEURO and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_POSTOPNEURO	1.074 [0.92, 1.25]	0.355
Birth year	0.993 [0.98, 1.0]	0.098

During the follow-up period (1.1.1998 — 31.12.2019), 273 out of 10559 females with G6_POSTOPNEURO died.

Males

Parameter	HR [95% CI]	p-value
G6_POSTOPNEURO	1.037 [0.9, 1.2]	0.615
Birth year	0.99 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 240 out of 4412 males with G6_POSTOPNEURO died.

Mortality risk

Mortality risk for people of age

years, who have G6_POSTOPNEURO.

N-year risk	Females	Males
1	0.117%	0.219%
5	0.627%	1.243%
10	1.585%	3.256%
15	2.824%	6.215%
20	4.87%	10.678%

Relationships between endpoints

↥

Index endpoint: G6_POSTOPNEURO – Postprocedural disorders of nervous system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Postprocedural disorders of nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints